The prevalence of GAD according to the ASCO recommendations (cut-off ≥ 10) was 15.3%, and the prevalence of GAD with a lower GAD-7 cut-off was 22.3% (cut-off ≥ 8) and 28.2% (cut-off ≥ 7). This evidence concerns the gene GAD1 and generalized anxiety disorder.